GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Clinical trial NCT01313598 · COMPLETED
Trial details
- NCT number
- NCT01313598
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.